Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
scientific article published on 10 September 2017
Author/s
author: Ana Arance, Jeffrey S Weber, Stéphane Dalle, Vanna Chiarion Sileni, Ivan Marquez-Rodas, Nicolas Meyer, Laurent Mortier, Georgina V. Long, Piotr Rutkowski, Paolo Antonio Ascierto, James Larkin
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.